TrademarkDir
XENOMAP
LIVE

Serial Number

97315606

Owner

CareDx, Inc.

Attorney

Theresa Conduah

Filing Date

Mar 16, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

XENOMAP Trademark

Serial Number: 97315606

XENOMAP is a trademark filed by CareDx, Inc. on March 16, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

CareDx, Inc. (56 trademarks)

3260 Bayshore Blvd.
Brisbane, CA 94005

Entity Type: 03

Trademark Details

Filing Date

March 16, 2022

Registration Date

Not Registered

Published for Opposition

May 2, 2023

Goods & Services

Biological test kits composed of medical diagnostic reagents and assays for testing body fluids and human tissue for use in transplant surveillance; diagnostic testing kits comprised of medical diagnostic reagents for transplant surveillance; Biological test kits comprised of medical diagnostic reagents for analysis of gene expression in inflammatory and immune response

Medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes; medical diagnostic testing services for transplant surveillance; medical diagnostic testing featuring analysis of gene expression in inflammatory and immune response

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 5, 2026 EXRA
SOU EXTENSION 5 GRANTED
Jan 5, 2026 EX5G
SOU TEAS EXTENSION RECEIVED
Dec 10, 2025 EEXT
SOU EXTENSION 5 FILED
Dec 9, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jun 6, 2025 EX4G
SOU EXTENSION 4 FILED
Jun 6, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 6, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 4, 2024 EXRA
SOU EXTENSION 3 GRANTED
Dec 3, 2024 EX3G
SOU EXTENSION 3 FILED
Dec 3, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 3, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2024 EXRA
SOU EXTENSION 2 GRANTED
Oct 28, 2024 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 28, 2024 AITU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Aug 2, 2024 TPEX
NOTICE OF REVIVAL - E-MAILED
Aug 2, 2024 NREV
PETITION TO REVIVE-GRANTED
Aug 2, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Aug 2, 2024 PROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 31, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 31, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 31, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 31, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 31, 2024 COAR
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 29, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 29, 2024 ABN6
SOU EXTENSION 2 FILED
Jun 27, 2024 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 20, 2023 EXRA
SOU EXTENSION 1 GRANTED
Dec 18, 2023 EX1G
SOU EXTENSION 1 FILED
Dec 18, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 18, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 27, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 2, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 2, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 12, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 23, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 23, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 23, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 23, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 12, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 12, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 12, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 18, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 22, 2022 NWOS
NEW APPLICATION ENTERED
Mar 19, 2022 NWAP

Related Trademarks

More from this Owner

ALLOCHIME

ALLOCHIME

VANTX

VANTX

ALLOSURE

ALLOSURE

ALLOSURE

ALLOSURE

TOGETHER IN TRANSPLANT

TOGETHER IN TRANSPLANT

TOGETHER IN TRANSPLANT

TOGETHER IN TRANSPLANT